Professor Neil Hawkins

  • Professor (Health Economics & Health Technology Assessment)

Biography

Neil holds a PhD in Pharmacology from the University of Bristol, Masters Degrees in Health Economics (York) and Applied Statistics (Sheffield), and also an MBA from the University of Oxford.  He has over 17 years experience in the field of HTA and has participated in over thirty health technology assessments covering a wide variety of clinical areas.  Previously he was a Reader in Health Technology Assessment (HTA) at the London School of Hygiene and Tropical Medicine, and Vice President leading the global Health Economics practice at ICON plc.

He has published numerous articles in international journals including Health Economics, Medical Decision Making, Heart and Value in Health. In addition he has conducted workshops discussing methods for evidence synthesis and decision analytic modelling in North and South America, Europe, Asia and Saudi Arabia, and also taught on short courses entitled ‘Introduction to Statistics’, ‘Introduction to Systematic Review and Meta-Analysis’ and ‘Development of Conceptual Models’ at meetings of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).


Research interests

Neil's research focuses on evidence synthesis and decision analytic modelling, precision medicine, and early stage health technology assessment.  He also acts as a consultant in HTA to the pharmaceutical and device industries providing both strategic and analytic advice, and has acted as an external consultant on the National Institute of Health and Clinical Excellence (NICE) Scientific Advice programme.


Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Development of a fully Bayesian framework for the identification and estimation of subgroup effects in Randomised Controlled Trials
    Medical Research Council
    2017 - 2020
     
  • An evidence-based evaluation of the clinical and cost-effectiveness of foot ulcer risk assessment and structured care interventions for people with diabetes
    National Institute for Health Research
    2017 - 2018
     
  • SRP Complex Reviews Research Support Unit
    National Institute for Health Research
    2015 - 2020
     

Supervision

  • Bouttell, Janet
    Methods of early health technology assessment in precision medicine

Publications

List by: Type | Date

Jump to: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011
Number of items: 18.

2019

Bouttell, J. , Teoh, J., Chiu, P. K., Chan, K. S., Ng, C.-F., Heggie, R. and Hawkins, N. (2019) Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong. PLoS ONE, 14(4), e0215279. (doi:10.1371/journal.pone.0215279) (PMID:30990840)

2018

Pennington, M., Grieve, R., Van der Meulen, J. and Hawkins, N. (2018) The value of external data in the extrapolation of survival data: a study using the NJR data set. Value in Health, 21(7), pp. 822-829. (doi:10.1016/j.jval.2017.12.023) (PMID:30005754)

Willis, S., De Corte, K., Cairns, J.A., Zia Sadique, M., Hawkins, N. , Pennington, M., Cho, G., Roberts, D.J., Miflin, G. and Grieve, R. (2018) Cost-effectiveness of alternative changes to a national blood collection service. Transfusion Medicine, (doi:10.1111/tme.12537) (PMID:29767450) (Early Online Publication)

Wright, C. M., Boudarène, L., Ha, N. T., Wu, O. and Hawkins, N. (2018) A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. BMC Public Health, 18, 373. (doi:10.1186/s12889-018-5261-8) (PMID:29558894) (PMCID:PMC5859762)

Beca, J., Husereau, D., Chan, K. K.W., Hawkins, N. and Hoch, J. S. (2018) Oncology modeling for fun and profit! Key steps for busy analysts in health technology assessment. PharmacoEconomics, 36(1), pp. 7-15. (doi:10.1007/s40273-017-0583-4) (PMID:29110141)

2017

Hawkins, N. and Grieve, R. (2017) Extrapolation of survival data in cost-effectiveness analyses. Medical Decision Making, 37(4), pp. 337-339. (doi:10.1177/0272989X17697019) (PMID:28355938)

Hawkins, N. , Heggie, R. and Wu, O. (2017) Reliable sources? Generating, selecting, and applying evidence to inform the health benefits package. In: Glassman, A., Giedion, U. and Smith, P.C. (eds.) What's In, What's Out: Designing Benefits for Universal Health Coverage. Brookings Institution Press, pp. 235-246. ISBN 9781944691059

2016

Mealing, S., Woods, B., Hawkins, N. , Cowie, M. R., Plummer, C. J., Abraham, W. T., Beshai, J. F., Klein, H. and Sculpher, M. (2016) Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart, 102(21), pp. 1742-1749. (doi:10.1136/heartjnl-2015-308883) (PMID:27411837)

Wu, O. , McMeekin, N. and Hawkins, N. (2016) Lost in Translation: Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction. ISPOR 19th Annual European Congress, Vienna, Austria, 29 Oct - 2 Nov 2016. A639. (doi:10.1016/j.jval.2016.09.1685)

2015

Woods, B., Hawkins, N. , Mealing, S., Sutton, A., Abraham, W.T., Beshai, J.F., Klein, H., Sculpher, M., Plummer, C.J. and Cowie, M.R. (2015) Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart, 101(22), pp. 1800-1806. (doi:10.1136/heartjnl-2015-307634) (PMID:26269413) (PMCID:PMC4680159)

2014

Ortega, A., Fraga, M.D., Alegre-del-Rey, E.J., Puigventós-Latorre, F., Porta, A., Ventayol, P., Tenias, J.M., Hawkins, N.S. and Caldwell, D.M. (2014) A checklist for critical appraisal of indirect comparisons. International Journal of Clinical Practice, 68(10), pp. 1181-1189. (doi:10.1111/ijcp.12487) (PMID:25269948)

2012

Hawkins, N. , Richardson, G., Sutton, A. J., Cooper, N. J., Griffiths, C., Rogers, A. and Bower, P. (2012) Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Economics, 21(6), pp. 742-756. (doi:10.1002/hec.1741) (PMID:21796723)

Reich, K., Burden, A.D., Eaton, J.N. and Hawkins, N.S. (2012) Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. British Journal of Dermatology, 166(1), pp. 179-188. (doi:10.1111/j.1365-2133.2011.10583.x) (PMID:21910698)

2011

Hawkins, N. and Scott, D. A. (2011) Reimbursement and value-based pricing: stratified cost-effectiveness analysis may not be the last word. Health Economics, 20(6), pp. 688-698. (doi:10.1002/hec.1625) (PMID:20568075)

Hoaglin, D. C. et al. (2011) Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value in Health, 14(4), pp. 429-437. (doi:10.1016/j.jval.2011.01.011) (PMID:21669367)

Jansen, J. P., Fleurence, R., Devine, B., Itzler, R., Barrett, A., Hawkins, N. , Lee, K., Boersma, C., Annemans, L. and Cappelleri, J. C. (2011) Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR task force on indirect treatment comparisons good research practices: part 1. Value in Health, 14(4), pp. 417-428. (doi:10.1016/j.jval.2011.04.002) (PMID:21669366)

Gross, J. L., Kramer, C. K., Leitão, C. B., Hawkins, N. , Viana, L. V., Schaan, B. D., Pinto, L. C., Rodrigues, T. C. and Azevedo, M. J. (2011) Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Annals of Internal Medicine, 154(10), pp. 672-679. (doi:10.7326/0003-4819-154-10-201105170-00007) (PMID:21576535)

Woods, B., Veenstra, D. and Hawkins, N. (2011) Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value in Health, 14(8), pp. 989-1001. (doi:10.1016/j.jval.2011.05.048) (PMID:22152167)

This list was generated on Fri May 24 00:02:27 2019 BST.
Number of items: 18.

Articles

Bouttell, J. , Teoh, J., Chiu, P. K., Chan, K. S., Ng, C.-F., Heggie, R. and Hawkins, N. (2019) Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong. PLoS ONE, 14(4), e0215279. (doi:10.1371/journal.pone.0215279) (PMID:30990840)

Pennington, M., Grieve, R., Van der Meulen, J. and Hawkins, N. (2018) The value of external data in the extrapolation of survival data: a study using the NJR data set. Value in Health, 21(7), pp. 822-829. (doi:10.1016/j.jval.2017.12.023) (PMID:30005754)

Willis, S., De Corte, K., Cairns, J.A., Zia Sadique, M., Hawkins, N. , Pennington, M., Cho, G., Roberts, D.J., Miflin, G. and Grieve, R. (2018) Cost-effectiveness of alternative changes to a national blood collection service. Transfusion Medicine, (doi:10.1111/tme.12537) (PMID:29767450) (Early Online Publication)

Wright, C. M., Boudarène, L., Ha, N. T., Wu, O. and Hawkins, N. (2018) A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. BMC Public Health, 18, 373. (doi:10.1186/s12889-018-5261-8) (PMID:29558894) (PMCID:PMC5859762)

Beca, J., Husereau, D., Chan, K. K.W., Hawkins, N. and Hoch, J. S. (2018) Oncology modeling for fun and profit! Key steps for busy analysts in health technology assessment. PharmacoEconomics, 36(1), pp. 7-15. (doi:10.1007/s40273-017-0583-4) (PMID:29110141)

Hawkins, N. and Grieve, R. (2017) Extrapolation of survival data in cost-effectiveness analyses. Medical Decision Making, 37(4), pp. 337-339. (doi:10.1177/0272989X17697019) (PMID:28355938)

Mealing, S., Woods, B., Hawkins, N. , Cowie, M. R., Plummer, C. J., Abraham, W. T., Beshai, J. F., Klein, H. and Sculpher, M. (2016) Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart, 102(21), pp. 1742-1749. (doi:10.1136/heartjnl-2015-308883) (PMID:27411837)

Woods, B., Hawkins, N. , Mealing, S., Sutton, A., Abraham, W.T., Beshai, J.F., Klein, H., Sculpher, M., Plummer, C.J. and Cowie, M.R. (2015) Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart, 101(22), pp. 1800-1806. (doi:10.1136/heartjnl-2015-307634) (PMID:26269413) (PMCID:PMC4680159)

Ortega, A., Fraga, M.D., Alegre-del-Rey, E.J., Puigventós-Latorre, F., Porta, A., Ventayol, P., Tenias, J.M., Hawkins, N.S. and Caldwell, D.M. (2014) A checklist for critical appraisal of indirect comparisons. International Journal of Clinical Practice, 68(10), pp. 1181-1189. (doi:10.1111/ijcp.12487) (PMID:25269948)

Hawkins, N. , Richardson, G., Sutton, A. J., Cooper, N. J., Griffiths, C., Rogers, A. and Bower, P. (2012) Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Economics, 21(6), pp. 742-756. (doi:10.1002/hec.1741) (PMID:21796723)

Reich, K., Burden, A.D., Eaton, J.N. and Hawkins, N.S. (2012) Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. British Journal of Dermatology, 166(1), pp. 179-188. (doi:10.1111/j.1365-2133.2011.10583.x) (PMID:21910698)

Hawkins, N. and Scott, D. A. (2011) Reimbursement and value-based pricing: stratified cost-effectiveness analysis may not be the last word. Health Economics, 20(6), pp. 688-698. (doi:10.1002/hec.1625) (PMID:20568075)

Hoaglin, D. C. et al. (2011) Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value in Health, 14(4), pp. 429-437. (doi:10.1016/j.jval.2011.01.011) (PMID:21669367)

Jansen, J. P., Fleurence, R., Devine, B., Itzler, R., Barrett, A., Hawkins, N. , Lee, K., Boersma, C., Annemans, L. and Cappelleri, J. C. (2011) Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR task force on indirect treatment comparisons good research practices: part 1. Value in Health, 14(4), pp. 417-428. (doi:10.1016/j.jval.2011.04.002) (PMID:21669366)

Gross, J. L., Kramer, C. K., Leitão, C. B., Hawkins, N. , Viana, L. V., Schaan, B. D., Pinto, L. C., Rodrigues, T. C. and Azevedo, M. J. (2011) Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Annals of Internal Medicine, 154(10), pp. 672-679. (doi:10.7326/0003-4819-154-10-201105170-00007) (PMID:21576535)

Woods, B., Veenstra, D. and Hawkins, N. (2011) Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value in Health, 14(8), pp. 989-1001. (doi:10.1016/j.jval.2011.05.048) (PMID:22152167)

Book Sections

Hawkins, N. , Heggie, R. and Wu, O. (2017) Reliable sources? Generating, selecting, and applying evidence to inform the health benefits package. In: Glassman, A., Giedion, U. and Smith, P.C. (eds.) What's In, What's Out: Designing Benefits for Universal Health Coverage. Brookings Institution Press, pp. 235-246. ISBN 9781944691059

Conference or Workshop Item

Wu, O. , McMeekin, N. and Hawkins, N. (2016) Lost in Translation: Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction. ISPOR 19th Annual European Congress, Vienna, Austria, 29 Oct - 2 Nov 2016. A639. (doi:10.1016/j.jval.2016.09.1685)

This list was generated on Fri May 24 00:02:27 2019 BST.